Yazar "Ahn, M-J." seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe CNS outcomes of lazertinib vs gefitinib in EGFR-mutated advanced NSCLC: A LASER301 subset analysis(Elsevier, 2023) Soo, R. A.; Cho, B. C.; Kim, J-H.; Ahn, M-J.; Lee, K. H.; Zimina, A.; Orlov, S.[Abstract Not Available]Öğe Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studies(Elsevier, 2023) Lee, Y-G.; Ahn, J. S.; Ahn, M-J.; Kang, J. H.; Soo, R. A.; Reungwetwattana, T.; Yang, J. C-H.[Abstract Not Available]Öğe A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)(Elsevier, 2022) Cho, B. C.; Ahn, M-J.; Kang, J. H.; Soo, R.; Baisamut (Reungwetwattana), T.; Yang, J. C-H.; Cicin, I.[Abstract Not Available]
